Overview
SYnAbs specializes in generating highly specific monoclonal antibodies against small molecules, membrane receptors, and transmembrane proteins. The company offers custom antibody development services and produces primary and secondary monoclonal antibodies for various applications including infectious diseases, epigenetic modifications, and cytokine research.
Something wrong or missing? Send an update. Fixed within 24 hours.